Get Ready for the RVO Revolution By: Arsham Sheybani, MD; Rajendra S. Apte, MD, PhD Injectable therapies move to the forefront, greatly expanding the options for clinicians Considering the Options for RVO Therapy By: John A Wells, III, MD; John J. Wroblewski, MD Peer-reviewed: Intraocular Inflammatory Disorders Update By: Olga M. Ceron, MD; David M. Hinkle, MD; C. Stephen Foster, MD A Safety Net for Retinopathy of Prematurity Management By: Lawrence Y. Ho, MD; Lisa J. Faia, MD; Michael T. Trese, M.D. New Web-based initiative could expand access to pediatric retina specialists nationwide RPS Recap: Exhibition of Inhibition By: Andrew E. Mathis, PhD, Medical Editor The final article in our series recapping research presented at our annual meeting Putting “Management” Into Risk Management By: Leslie Goldberg, Associate Editor Proactive policies for keeping patients safe Bringing Combined Procedures Into the Mainstream By: Robert A. Sisk, MD; Timothy G. Murray, MD, MBA Posterior-segment Complications of Keratorefractive Surgery By: Stephen G. Schwartz, MD, MBA; Thomas A. Albini , MD; Harry W. Flynn, Jr., MD Short-pulse Laser Treatment: Redefining Retinal Treatment By: Daniel Palanker, PhD; Yannis M. Paulus, MD; Mark S. Blumenkranz, MD Minimizing side effects without compromising care Controversies in the Long-term Management of Neovascular AMD By: Scott W. Cousins, MD The role of imaging in clinical decision making Case Report By: Chirag P. Shah, MD, MPH Massive Papilledema due to Hydrocephalus Special section sponsored by Alcon By: Sunil Gupta, MD; Alan Franklin, MD, PhD; John P. Myers, MD Reusables vs. Disposables: A Safe Conclusion for DSPs Upfront From the editor-in-chief Subspecialty News By: Jerry Helzner, Senior Editor; Leslie Goldberg, Associate Editor; Andrew E. Mathis, PhD, Medical Editor Sustained-release Lucentis; TADRS; PVD Journal Club Recent noteworthy studies to stimulate debate Coding Q&A By: Riva Lee Asbell Medicare consultation codes no longer used Clinical Trial Spotlight By: Andrew E. Mathis, PhD, Medical Editor Genzyme tests viral vector for wet AMD Clinical Trials Update Products & Services Calendar Focus On By: Leslie Goldberg, Associate Editor Patient-tailored Retina Treatments Could Improve Safety and Predictability Current Issue: January 2010
		| © Lippincott Williams & Wilkins VisionCare Group All Rights Reserved - Terms and Conditions of Service